Suppr超能文献

溶质载体家族中的氨基酸转运蛋白:被低估的蛋白质和癌症治疗的新机会。

Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.

机构信息

Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

Mol Metab. 2024 Jun;84:101952. doi: 10.1016/j.molmet.2024.101952. Epub 2024 May 3.

Abstract

BACKGROUND

Solute carrier (SLC) transporters, a diverse family of membrane proteins, are instrumental in orchestrating the intake and efflux of nutrients including amino acids, vitamins, ions, nutrients, etc, across cell membranes. This dynamic process is critical for sustaining the metabolic demands of cancer cells, promoting their survival, proliferation, and adaptation to the tumor microenvironment (TME). Amino acids are fundamental building blocks of cells and play essential roles in protein synthesis, nutrient sensing, and oncogenic signaling pathways. As key transporters of amino acids, SLCs have emerged as crucial players in maintaining cellular amino acid homeostasis, and their dysregulation is implicated in various cancer types. Thus, understanding the intricate connections between amino acids, SLCs, and cancer is pivotal for unraveling novel therapeutic targets and strategies.

SCOPE OF REVIEW

In this review, we delve into the significant impact of amino acid carriers of the SLCs family on the growth and progression of cancer and explore the current state of knowledge in this field, shedding light on the molecular mechanisms that underlie these relationships and highlighting potential avenues for future research and clinical interventions.

MAJOR CONCLUSIONS

Amino acids transportation by SLCs plays a critical role in tumor progression. However, some studies revealed the tumor suppressor function of SLCs. Although several studies evaluated the function of SLC7A11 and SLC1A5, the role of some SLC proteins in cancer is not studied well. To exert their functions, SLCs mediate metabolic rewiring, regulate the maintenance of redox balance, affect main oncogenic pathways, regulate amino acids bioavailability within the TME, and alter the sensitivity of cancer cells to therapeutics. However, different therapeutic methods that prevent the function of SLCs were able to inhibit tumor progression. This comprehensive review provides insights into a rapidly evolving area of cancer biology by focusing on amino acids and their transporters within the SLC superfamily.

摘要

背景

溶质载体(SLC)转运蛋白是一类多样化的膜蛋白家族,在调节营养物质(包括氨基酸、维生素、离子、营养素等)的跨细胞膜摄取和外排方面发挥着重要作用。这个动态过程对于维持癌细胞的代谢需求、促进其存活、增殖和适应肿瘤微环境(TME)至关重要。氨基酸是细胞的基本组成部分,在蛋白质合成、营养感应和致癌信号通路中发挥着重要作用。作为氨基酸的关键转运体,SLC 在维持细胞内氨基酸稳态方面发挥着重要作用,其失调与多种癌症类型有关。因此,了解氨基酸、SLC 和癌症之间的复杂联系对于揭示新的治疗靶点和策略至关重要。

综述范围

在这篇综述中,我们深入探讨了 SLC 家族的氨基酸载体对癌症生长和进展的重大影响,并探讨了该领域的现有知识状况,阐明了这些关系背后的分子机制,并强调了未来研究和临床干预的潜在途径。

主要结论

SLC 转运氨基酸在肿瘤进展中起着关键作用。然而,一些研究揭示了 SLC 的肿瘤抑制功能。尽管有几项研究评估了 SLC7A11 和 SLC1A5 的功能,但一些 SLC 蛋白在癌症中的作用尚未得到很好的研究。为了发挥其功能,SLC 介导代谢重编程、调节氧化还原平衡的维持、影响主要致癌途径、调节 TME 内氨基酸的生物利用度以及改变癌细胞对治疗的敏感性。然而,不同的治疗方法可以阻止 SLC 的功能,从而抑制肿瘤的进展。通过关注 SLC 超家族中的氨基酸及其转运体,本综述全面综述为癌症生物学的一个快速发展领域提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d073/11112377/33561f84b66c/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验